Nano-Enabled Drug Delivery: Exploring Cancer Treatment Opportunities
Alan Porter Ph.D., and Jing Ma; Ivan Allen School of Public Policy
Georgia Institute of Technology

Abstract: We compile large sets of nano-related article and patent abstracts.  We then analyze these records to learn about changing research emphases to try to project likely future developmental pathways. In this seminar we will focus on Nano-Enabled Drug Delivery (NEDD), considering key emerging topics over time.  We will then focus on NEDD being used to treat cancers.  We key on 3 dimensions:

• Which nano components are being researched?
• To facilitate delivery of which agents (drugs)?
• To treat which cancers?

A key aim is to identify R&D opportunities that have not been well-explored yet.

 Bio: Alan Porter is Professor Emeritus of Industrial & Systems Engineering, and of Public Policy, at Georgia Tech, where he remains Co-director of the Technology Policy and Assessment Center.  He is also Director of R&D for Search Technology, Inc. (Norcross, GA).  He is author of some 230 articles and books, including Tech Mining (Wiley, 2005) and Forecasting and Management of Technology (Wiley, 2011).  Current research emphasizes “forecasting innovation pathways” for selected nanotechnologies.  This entails text mining of science, technology & innovation information resources.

Jing Ma is completing her PhD at Beijing Institute of Technology (BIT), and has been a visiting scholar at Georgia Tech for 2013-2014. Her research interest is technology innovation management and tech mining. Her current research has been focusing on identifying technology development pathways and opportunities of Nano-Enabled Drug Delivery.